Evidence map›Paper›PMID 35637251›Full record

ArticleOncogene2022

Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma.

Marina Georgiou, Panagiota Ntavelou, William Stokes, Rajat Roy, Geoffrey J Maher, Tsvetana Stoilova, Josephine A M Y Choo, Callum P Rakhit, Miguel Martins, Paul Ajuh and 5 more

Abstract readPublished Erratum
In one paragraph

Article in Oncogene, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Marina Georgiou *Division of Cancer, Department of Surgery and Cancer, Imperial College, London, UK.
Panagiota Ntavelou *Division of Cancer, Department of Surgery and Cancer, Imperial College, London, UK.
William StokesDivision of Cancer, Department of Surgery and Cancer, Imperial College, London, UK.
Rajat RoyDivision of Cancer, Department of Surgery and Cancer, Imperial College, London, UK.
Geoffrey J MaherDivision of Cancer, Department of Surgery and Cancer, Imperial College, London, UK.ORCID http://orcid.org/0000-0001-7135-4824
Tsvetana StoilovaDivision of Cancer, Department of Surgery and Cancer, Imperial College, London, UK.
Josephine A M Y ChooDivision of Cancer, Department of Surgery and Cancer, Imperial College, London, UK.
Callum P RakhitMRC Toxicology Unit, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-5185-7405
Miguel MartinsMRC Toxicology Unit, University of Cambridge, Cambridge, UK.
Paul AjuhGemini Biosciences, Liverpool, UK.
Neil HorowitzDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Ross S BerkowitzDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Kevin EliasDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Michael J SecklDivision of Cancer, Department of Surgery and Cancer, Imperial College, London, UK. m.seckl@imperial.ac.uk.ORCID http://orcid.org/0000-0003-4078-2599
Olivier E PardoDivision of Cancer, Department of Surgery and Cancer, Imperial College, London, UK. o.pardo@imperial.ac.uk.ORCID http://orcid.org/0000-0003-2223-1435

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35637251
PMCPMC9232390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.